The human myeloid cell nuclear differentiation antigen (MNDA) is a protein of 406 amino acids that is expressed specifically in granulocytes, monocytes and earlier stage cells of these lineages. Degenerate oligonucleotides that could encode regions of MNDA amino acid sequence were used to amplify the MNDA cDNA sequence using the polymerase chain reaction. The amplified cDNA product was sequenced to confirm that it encoded the MNDA protein. It was then used as a probe to isolate five clones from a human bone marrow lambda gt10 cDNA library. A clone containing a 1,672 base pair cDNA insert was sequenced and found to encode the entire MNDA open reading frame, as well as 5' and 3' untranslated regions. The primary structure of the MNDA contains extensive regions of sequence similarity with the protein products of the interferon-inducible genes: 204 and interferon regulatory factor 2. In addition, a 12-base sequence matching the interferon-stimulated response element consensus sequence [GAAAN(N)GAAA] is located in the 5' untranslated region of the MNDA cDNA. The 1.8 kb MNDA mRNA was detected only in cells that express the antigen and the level of MNDA mRNA was elevated in cells treated with either recombinant or natural interferon alpha. The MNDA mRNA was not induced by interferon alpha in cells that do not exhibit a constitutive level of the MNDA mRNA. The MNDA contains sequence motifs found in gene regulatory proteins. The expression and the primary structure of the MNDA indicates that it plays a role in the granulocyte/monocyte cell-specific response to interferon.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/jcb.240490114 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification and validation of hub differential genes in pulmonary sarcoidosis.
Front Immunol
October 2024
Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Article Synopsis
- A total of 138 candidate differentially expressed genes (cDEGs) were identified from mediastinal lymph nodes and peripheral blood samples related to pulmonary sarcoidosis.
- Six key cDEGs—CTSS, CYBB, FPR2, MNDA, TLR1, and TLR8—showed significantly higher expression levels in sarcoidosis patients compared to healthy controls, suggesting their potential role in the disease.
- The analysis highlighted important pathways linked to immune and inflammatory responses, indicating that these hub cDEGs could help enhance diagnosis and understanding of pulmonary sarcoidosis mechanisms.
Identifying Biomarkers and Therapeutic Targets by Multiomic Analysis for HNSCC: Precision Medicine and Healthcare Management.
ACS Omega
March 2024
Department of Mechanics and Aerospace Engineering, College of Engineering, Southern University of Science and Technology, Shenzhen 518055, Guangdong, China.
Head and neck squamous cell carcinoma (HNSCC) is one of the major types of cancer, with 900,000 cases and over 400,000 deaths annually. It constitutes 3-4% of all cancers in Europe and western countries. As early diagnosis is the key to treating the disease, reliable biomarkers play an important role in the precision medicine of HNSCC.
View Article and Find Full Text PDFMis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD.
Sci Transl Med
February 2024
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Functional loss of TDP-43, an RNA binding protein genetically and pathologically linked to amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), leads to the inclusion of cryptic exons in hundreds of transcripts during disease. Cryptic exons can promote the degradation of affected transcripts, deleteriously altering cellular function through loss-of-function mechanisms. Here, we show that mRNA transcripts harboring cryptic exons generated de novo proteins in TDP-43-depleted human iPSC-derived neurons in vitro, and de novo peptides were found in cerebrospinal fluid (CSF) samples from patients with ALS or FTD.
View Article and Find Full Text PDFTranscriptomic analysis reveals shared gene signatures and molecular mechanisms between obesity and periodontitis.
Front Immunol
April 2023
Laboratory of Molecular and Statistical Genetics and Hunan Provincial Key Laboratory of Animal Intestinal Function and Regulation, College of Life Sciences, Hunan Normal University, Changsha, China.
Background: Both obesity (OB) and periodontitis (PD) are chronic non-communicable diseases, and numerous epidemiological studies have demonstrated the association between these two diseases. However, the molecular mechanisms that could explain the association between OB and PD are largely unclear. This study aims to investigate the common gene signatures and biological pathways in OB and PD through bioinformatics analysis of publicly available transcriptome datasets.
View Article and Find Full Text PDFin amyotrophic lateral sclerosis: from genetic association to therapeutic target.
J Neurol Neurosurg Psychiatry
August 2023
Department of Neurology, UMC Utrecht Brain Center Rudolf Magnus, Utrecht, The Netherlands
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with limited treatment options and an incompletely understood pathophysiology. Although genomewide association studies (GWAS) have advanced our understanding of the disease, the precise manner in which risk polymorphisms contribute to disease pathogenesis remains unclear. Of relevance, GWAS have shown that a polymorphism (rs12608932) in the gene is associated with risk for both ALS and frontotemporal dementia (FTD).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!